VIROMARKERS at EASL 2026 Highlights

We are glad to have brought the VIROMARKERS project to the European Association for the Study of the Liver Congress (EASL 2026), held in Barcelona, Spain from 27 to 30 May 2026.

The congress was a valuable opportunity to present our recent research and engage with the scientific community working in liver disease.

It also provided a clear view of how current studies are evolving and how our work fits within the broader direction of the field.

We are ready to continue our activities and look ahead to upcoming scientific events!

Find out more about the event here: https://www.easlcongress.eu/

Discover our presentations below:

Oral presentations:

Long-read sequencing unveils extensive HBV-DNA integration driving massive HBsAg production and sustaining HDV persistence

Stefano D’Anna (UTOV)

Posters:

Genetic diversification in hepatitis Delta antigen and ribozyme correlates with altered virological and biochemical markers and may inform novel therapeutic targets

Alessia Magnapera (UTOV)

also Poster Tour

High burden of active HDV infection and broad genetic diversity of HDV in Cameroon: insights from molecular diagnostics and whole-genome sequencing

Lorenzo Piermatteo (UTOV)

Distinct patterns of HBsAg isoform reflect viral activity and characterize disease stage in the setting of chronic HDV infection

Ilaria Grossi (UTOV)

The implementation of double reflex testing reveals a still relevant burden of HDV infection across Europe and represents a valuable strategy to increase HDV diagnosis at an earlier stage of liver disease

Romina Salpini (UTOV)

Subgenotype discrepancies in hepatitis delta virus highlight the need for a unified phylogenetic classification

Ana Alberola Romano (Hospital Universitario Clinico San Cecilio/UTOV)